SV Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SV Pharma
Largest movements
- Receivables within one year +€26,722
up €26,722 (+129.8%), from €20,584 to €47,306
of which Other amounts receivable: +€24,819
- Deferred charges and accrued income +€10,715
up €10,715 (+182.2%), from €5,881 to €16,596
- Reserves +€61,150
up €61,150 (+56.0%), from €109,123 to €170,273
- Debts after one year -€37,807
down €37,807 (-6.6%), from €574,598 to €536,792
of which Financial debts: -€37,807
- Gross operating margin +€25,821
up €25,821, from -€19,414 to €6,407
- Taxes +€2,320
up €2,320 (+56.0%), from €4,143 to €6,463
- Other operating charges +€599
up €599 (+131.6%), from €455 to €1,054
- Financial charges -€485
down €485 (-8.1%), from €5,993 to €5,508
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €778,381 | €814,509 | +€36,128 | +4.6% |
| Formation expenses | 20 | €3,445 | €1,647 | -€1,798 | -52.2% |
| Fixed assets | 21/28 | €739,636 | €740,879 | +€1,243 | +0.2% |
| Tangible fixed assets | 22/27 | €202 | €1,445 | +€1,243 | +614.1% |
| Plant, machinery and equipment | 23 | €202 | €1,445 | +€1,243 | +614.1% |
| Financial fixed assets | 28 | €739,434 | €739,434 | = | 0.0% |
| Current assets | 29/58 | €35,300 | €71,983 | +€36,683 | +103.9% |
| Amounts receivable within one year | 40/41 | €20,584 | €47,306 | +€26,722 | +129.8% |
| Trade receivables | 40 | €0 | €1,903 | +€1,903 | |
| Other amounts receivable | 41 | €20,584 | €45,403 | +€24,819 | +120.6% |
| Cash at bank and in hand | 54/58 | €8,836 | €8,082 | -€754 | -8.5% |
| Deferred charges and accrued income | 490/1 | €5,881 | €16,596 | +€10,715 | +182.2% |
| Total equity and liabilities | 10/49 | €778,381 | €814,509 | +€36,128 | +4.6% |
| Equity | 10/15 | €159,123 | €220,273 | +€61,150 | +38.4% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €109,123 | €170,273 | +€61,150 | +56.0% |
| Distributable reserves | 133 | €109,123 | €170,273 | +€61,150 | +56.0% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €619,258 | €594,236 | -€25,023 | -4.0% |
| Amounts payable after more than one year | 17 | €574,598 | €536,792 | -€37,807 | -6.6% |
| Financial debts | 170/4 | €253,447 | €215,640 | -€37,807 | -14.9% |
| Other amounts payable | 178/9 | €321,151 | €321,151 | = | 0.0% |
| Amounts payable within one year | 42/48 | €44,619 | €57,436 | +€12,817 | +28.7% |
| Current portion of amounts payable after more than one year | 42 | €37,387 | €37,807 | +€419 | +1.1% |
| Trade debts | 44 | €753 | €6,221 | +€5,469 | +726.7% |
| Suppliers | 440/4 | €753 | €6,221 | +€5,469 | +726.7% |
| Taxes, remuneration and social security | 45 | €5,870 | €12,798 | +€6,929 | +118.0% |
| Taxes | 450/3 | €5,870 | €12,798 | +€6,929 | +118.0% |
| Other amounts payable | 47/48 | €609 | €609 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €41 | €8 | -€33 | -79.7% |
| Non-recurring operating income | 76A | - | €2,291 | +€2,291 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,082 | €2,232 | +€150 | +7.2% |
| Other operating charges | 640/8 | €455 | €1,054 | +€599 | +131.6% |
| Gross operating margin | 9900 | -€19,414 | €6,407 | +€25,821 | |
| Operating profit (loss) | 9901 | -€21,951 | €3,121 | +€25,072 | |
| Financial income | 75/76B | €70,000 | €70,000 | = | 0.0% |
| Recurring financial income | 75 | €70,000 | €70,000 | = | 0.0% |
| Financial charges | 65/66B | €5,993 | €5,508 | -€485 | -8.1% |
| Recurring financial charges | 65 | €5,993 | €5,508 | -€485 | -8.1% |
| Profit (loss) for the period before taxes | 9903 | €42,056 | €67,613 | +€25,557 | +60.8% |
| Income taxes | 67/77 | €4,143 | €6,463 | +€2,320 | +56.0% |
| Profit (loss) for the period | 9904 | €37,913 | €61,150 | +€23,237 | +61.3% |
| Profit (loss) for the period to be appropriated | 9905 | €37,913 | €61,150 | +€23,237 | +61.3% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.